Fulgent Genetics Balance Sheet Health
Financial Health criteria checks 4/6
Fulgent Genetics has a total shareholder equity of $1.1B and total debt of $2.9M, which brings its debt-to-equity ratio to 0.3%. Its total assets and total liabilities are $1.2B and $98.9M respectively.
Key information
0.3%
Debt to equity ratio
US$2.91m
Debt
| Interest coverage ratio | n/a |
| Cash | US$213.07m |
| Equity | US$1.13b |
| Total liabilities | US$98.87m |
| Total assets | US$1.23b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7F0's short term assets ($326.5M) exceed its short term liabilities ($74.0M).
Long Term Liabilities: 7F0's short term assets ($326.5M) exceed its long term liabilities ($24.9M).
Debt to Equity History and Analysis
Debt Level: 7F0 has more cash than its total debt.
Reducing Debt: 7F0's debt to equity ratio has increased from 0% to 0.3% over the past 5 years.
Debt Coverage: 7F0's debt is well covered by operating cash flow (377.8%).
Interest Coverage: Insufficient data to determine if 7F0's interest payments on its debt are well covered by EBIT.